![Joris Wilms](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joris Wilms
Keine laufenden Positionen mehr
Profil
Joris Wiel Jan Wilms formerly worked at Genmab A, as Associate Director-Clinical Development from 2008 to 2010, KLIFO A, as Vice President-Clinical Trial Services from 2010 to 2016, and Y-mAbs Therapeutics, Inc., as Chief Operating Officer & Senior Vice President from 2017 to 2025.
Mr. Wilms received his graduate degree from the University of Groningen.
Ehemalige bekannte Positionen von Joris Wilms
| Unternehmen | Position | Ende |
|---|---|---|
| YMAS THER | Geschäftsführer | 16.09.2025 |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Corporate Officer/Principal | 01.01.2016 |
| GENMAB A/S | Corporate Officer/Principal | 01.12.2010 |
Ausbildung von Joris Wilms
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
8
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
